13 results
PRE 14A
ALLO
Allogene Therapeutics Inc
14 Apr 22
Preliminary proxy
4:10pm
a conflict of interest, the Compensation Committee engaged Compensia as a compensation consultant. The Compensation Committee requested that Compensia … consultant has raised any conflict of interest, taking into consideration the following factors: (i) the provision of other services to our Company
DEF 14A
h16m 577r13
24 Apr 19
Definitive proxy
8:01am
8-K
EX-3.2
ovf50
15 Oct 18
Allogene Therapeutics Announces Closing of Initial Public Offering
5:28pm
DRS
EX-4.2
dhqspnx5dk528y
10 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next